Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Operating expenses
General and administrative expenses	$ 275,866	$ 389,349
Research and development	19,033	142,793
Total operating expenses	294,899	532,142
Loss from operations	(294,899)	(532,142)
Other expense
Interest expense	(149,233)	(151,499)
Total other expense	(149,233)	(151,499)
Net loss	$ (444,132)	$ (683,641)
Loss per share - basic	$ (0.00)	$ (0.00)
Loss per share - diluted	$ (0.00)	$ (0.00)
Weighted average number of shares - basic	461,894,537	437,704,501
Weighted average number of shares - diluted	461,894,537	437,704,501